No Data
BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $36
Pfizer Options Spot-On: On September 13th, 103.23K Contracts Were Traded, With 3.08 Million Open Interest
Pfizer Inc. (PFE): A Bull Case Theory
Moderna's Faces 'Material Headwinds' on RSV, COVID, RBC Says
"Florida Discourages Use Of MRNA Covid Vaccines In Older Adults; In Updated Guidance To Health Care Providers, Florida Health Officials Advise That "Non-mRNA Covid-19 Vaccines And Treatment" Should Be Prioritized" - NBC News
US stocks are mixed, with vaccine concept stocks rising and falling, novavax (NVAX.US) up more than 5.4%.
As of press time, the stock has risen more than 5.4%, closing at $12.57.
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Deep Sea : Will rise above 30 after the consolidation. It is still undervalued.